D-dimer landmark trials: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 6: | Line 6: | ||
==PROLONG-II Study (NCT00266045)== | ==PROLONG-II Study (NCT00266045)== | ||
==The Negative Predictive Value of D-dimer on the Risk of Recurrent Venous Thromboembolism in Patients With Multiple Previous Events: a Prospective Cohort Study (NCT00428441)== | ==The Negative Predictive Value of D-dimer on the Risk of Recurrent Venous Thromboembolism in Patients With Multiple Previous Events: a Prospective Cohort Study (NCT00428441)== | ||
==VAPRED (NCT00860106) | |||
==References== | ==References== | ||
Revision as of 15:06, 25 September 2013
|
D-Dimer Microchapters |
|
Clinical Correlation |
|---|
|
Clinical Trials |
|
D-dimer landmark trials On the Web |
|
American Roentgen Ray Society Images of D-dimer landmark trials |
|
Risk calculators and risk factors for D-dimer landmark trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
PROLONG Study (NCT00264277)
PROLONG-II Study (NCT00266045)
The Negative Predictive Value of D-dimer on the Risk of Recurrent Venous Thromboembolism in Patients With Multiple Previous Events: a Prospective Cohort Study (NCT00428441)
==VAPRED (NCT00860106)